What do we learn about love through cancer and psychedelic journeys? And what if psychedelic medicines could help you find meaning without needing religion to justify it?

In this episode, we speak with Ryan Meeks, founder of Nautilus Integration and author of "Life is a Gift, Love is the Point." Ryan spent sixteen years as a megachurch pastor before his 2017 Hodgkin's lymphoma diagnosis accelerated his departure from Christianity and opened him to psychedelic healing. He now guides people through integration while emphasizing fitness, embodiment, and relationships.

Ryan and I explore cancer as purifying fire that burns away everything inessential, leaving only what matters. We discuss how psychedelics delivered what religion promised but couldn't provide, why love must be verb not just feeling, and how his pastoral skills translate to holding space during vulnerable journeys. Ryan describes the paradox of protective dissociation during cancer treatment and the challenging work of re-embodiment afterward.

Visit www.healingcancerjourneys.org and follow us on Instagram, TikTok, YouTube, and Substack at 'healingcancerjourneys'.

How do families heal together when cancer detonates through entire family systems, leaving everyone wounded?

In this episode, we speak with Ismail Ali, co-Executive Director at MAPS and psychedelic policy architect. Ismail holds a law degree from UC Berkeley, co-founded the Psychedelic Bar Association, and has been remarkably open about his family's use of ayahuasca ceremony to process grief after his mother's death from cancer. We explore how cancer grief and psychedelic use both carry profound stigma that isolates families in their suffering, and how Ismail's family courageously gathered three generations for ceremony even though his mother had fled Colombia partly to escape drug-related violence.

We also discuss MAPS's people-centered approach across three pillars: policy advocacy including Right to Try and Freedom to Heal Act, research establishing safety and efficacy, and education translating complex information for patients and providers. After forty years, MAPS is transitioning into an orchestration role, coordinating diverse organizations while keeping actual humans at the center of every decision. Ismail reminds us that policy work can become dehumanizing and abstract, but at the end of the day, if one person gets impacted by safe legal access to psychedelic medicines, that is everything.

You can find us online at www.healingcancerjourneys.org. Follow us on Instagram, TikTok, YouTube, and Substack at @healingcancerjourneys.

How do you cultivate hope that motivates you through cancer treatment without falling into magical thinking that prevents you from living in the present?

In this episode, we speak with Dr. Tony Back, palliative care physician, oncologist, psychedelic researcher and Zen practitioner. Tony explores the paradox of hope in cancer—how it can be essential for survival while simultaneously pulling us away from present-moment awareness. He offers both clinical and contemplative perspectives on healthy hope versus toxic positivity.

We also discuss Tony's strategic approach to social change, from training oncologists in difficult conversations to becoming the first physician to publicly share his psilocybin experience. His recent research on psychedelics among healthcare workers received 2,200 applications for 30 slots, revealing how psychedelic medicines might heal both patients and the doctors caring for them.

You can find us online at www.healingcancerjourneys.org and follow us on Instagram, TikTok, YouTube, and Substack where our handle is healingcancerjourneys.

How do oncologists witness death after death without burning out? And what happens when the medical system trains oncologists to see death as ‘failure’ rather than a natural outcome?

In this episode, we speak with Dr. Jason Konner, founder of Psychedelic Oncology and medical oncologist who practiced at Memorial Sloan Kettering for over two decades before leaving to pursue psychedelic medicine full-time. Jason discusses the concept of wounded healers and how oncologists often carry accumulated grief with nowhere to process it. He shares discovering ayahuasca after years of unrecognized burnout, which revealed a third way of being present with patients without depleting himself. We explore why psychedelic literacy among healthcare providers matters for patient care and Jason's vision for psychedelic oncology as a subspecialty addressing the existential, emotional, and spiritual dimensions that conventional cancer care systematically ignores.

How do you customize psychedelic retreats for people whose medical experiences were traumatic and whose bodies tried to kill them?

In this episode, we speak with Anne Hamilton, founder of Survivorship Collective—the first nonprofit offering legal psilocybin retreats designed specifically for cancer survivors. Anne walks us through the four-step process: medical screening for drug interactions, deliberate cohort matching for emotional safety, multi-week preparation that bonds participants, and five-day Oregon retreats with ongoing integration afterward.

Visit www.healingcancerjourneys.org and follow us at 'healingcancerjourneys'.

Andhow do we build the infrastructure for safe, legal, affordable accessto psychedelic medicines for people living with cancer?

Inthis episode, we speak with Dr. Linda Carlson, professor ofpsychosocial oncology and co-principal investigator of the CanadianNetwork for Psychedelic-Assisted Cancer Therapy (CAN-PACT), Canada's$5 million initiative building research infrastructure forpsychedelic-assisted cancer therapy. Linda explores what hersystematic review of research actually shows: promising signals butalso knowledge gaps. We discuss why healthcare providers seepotential but identify concerns about psychedelic medicines, and why"demoralization syndrome" may better capture cancer'spsychological impact than depression or anxiety.

Lindadescribes CAN-PACT's approach: building networks with patients asfull partners, identifying top research priorities through consensus,and training therapists in public cancer centers for equitableaccess.

How do you choose which psychedelic medicine is right for your cancer journey when you're navigating legal restrictions, confusing terminology, and your own intuition about what feels safe?

In this episode, Dan speaks with Angela Amirault, founder of Altered Healing and a psychedelic-assisted therapist practicing in Nova Scotia. Angela holds a BA in Psychology, a Graduate Diploma in Counseling and Psychotherapy, and advanced credentialing in mindfulness-based psychedelic therapy from the Center for Medicinal Mindfulness. She has guided over 500 medicine sessions with cannabis, ketamine, and psilocybin, and was the first practitioner in the United States to legally offer retreats combining cannabis and psilocybin.

Angela and Dan explore how to navigate the landscape of psychedelic medicines for cancer patients. They discuss the distinct qualities of cannabis (embodied, gentle, holding), ketamine (disconnective, observational, brief), and psilocybin (expansive, ancient, transcendent), and why Angela asks clients "what do you feel called to?" rather than prescribing specific substances. The conversation covers practical protocol details—preparation sessions, medicine experiences, and integration support—and addresses the challenging reality that legal access often determines options before personal preference can. Angela emphasizes finding guides who can create genuine safety, explains how different medicines help with the bodily alienation cancer creates, and shares why self-compassion emerges as the common thread across all psychedelic experiences for cancer patients.

Healing Cancer Journeys is a non-profit organization providing education and community for people exploring psychedelic medicines in their cancer journeys. Learn more at www.healingcancerjourneys.org and follow us on Instagram, TikTok, YouTube, and Substack where our handle is 'healingcancerjourneys'.

What if the tumor trying to kill you could actually heal you? And what if the boring policy details around psychedelic access matter more than the mystical experiences themselves?

In this episode, we speak with Ashley Lukens, cancer thriver and co-founder of Clarity Project, Hawaii's leading psychedelic advocacy organization. Ashley holds a PhD in Political Science and has spent over two decades advancing environmental justice, food sovereignty, and now psychedelic medicine access. After receiving a premonitory vision during an ayahuasca ceremony just ten days before her stage II brain cancer diagnosis in 2017, Ashley has integrated psychedelic medicines into her healing journey alongside conventional treatment.

Ashley shares her radical reframing of cancer through the mantra "I heal my tumor and my tumor heals me"—a perspective most cancer patients struggle to imagine. We explore how psychedelic medicines helped her work with the nine key factors in Radical Remission, particularly around trusting intuition, finding purpose, and becoming CEO of her own cancer care. We also dig into the unglamorous but critical nuts and bolts of psychedelic access: cost structures, insurance coverage, banking regulations, and implementation frameworks that determine whether cancer patients can actually access these medicines or just read about them in headlines.

This podcast is brought to you by Healing Cancer Journeys, a non-profit organization providing education and community for people exploring psychedelic medicines in their cancer journeys. You can find us online at www.healingcancerjourneys.org or follow us on Instagram, TikTok, YouTube, and Substack where our handle is 'healingcancerjourneys'.